3 ms·
It is good that people are doing studies, but at this point adding one more study isn't really headline news so I'm not sure what the up-voters think this will
by roenxi 5y ago
It is good that people are doing studies, but at this point adding one more study isn't really headline news so I'm not sure what the up-voters think this will show. There isn't really a need for more evidence as far as I'm aware.
What is far more interesting and useful is explanations of why there are a bunch of studies showing great COVID outcomes when patients are paired with Ivermectin (eg, https://ivmmeta.com/ https://ivmmeta.com/). The best answer I've heard is the geographic distribution of successful studies lines up with parasite-prone countries, so they are actually an interesting example of the base-rate effect.
- ggm 5y agoSo in laymans terms, enough people had untreated and undiagnosed parasitic infections that "they got better" was curing an undiagnosed comorbidity to a positive C19 and since the parasite causes high risk problems eg with kidneys or pulmonary risk or breathing, it helped them survive. Is that it?
- jasonhansel 5y agoIt's also that treatment with dexamethasone may be dangerous in patients with preexisting Strongyloides infections. Astral Codex Ten has an (admittedly rather speculative) take on this: https://astralcodexten.substack.com/p/ivermectin-much-more-than-you-wanted?utm_source=url https://astralcodexten.substack.com/p/ivermectin-much-more-t...
- inter_netuser 5y agoI'd also say covid case/severity reporting is probably of questionable quality in those regions as well, as they struggle economically and probably don't have resources to do that well.
- arn 5y agoMany of the early studies weren’t high quality studies. And as I recall a couple were outright fabricated. It takes time to run randomized prospective studies and those are coming out now.
- roenxi 5y agoIf we have lots of low quality studies that show Ivermectin works well in populations which probably have high parasite incidence, and not much obvious effect of anything in populations where there aren't many parasites (insert puns here about lawyers and politicians)... What is the high quality study here to prove? I don't see why the problem is evidence. AFAIK there seems to just be a shortage of people repeating "the helpful effect is geographically correlated" over and over again. Unless there is evidence of a positive effect that I'm not aware of?
- ayngg 5y agoI think the difference is that in places where ivermectin had efficacy (India, Sub Saharan Africa, South America), parasitic infection was a significant comorbidity. In much of the developed world, the most significant comorbidities are things like obesity and age (with all of its associated pulmonary and respiratory risks).
- raphlinus 5y agoA lot of it is just straight-up fraud. Gideon Meyerowitz-Katz has documented this in some detail. Also, ivnmeta itself is just weird. It can only be characterized as a propaganda site. It's well done, but scientifically invalid. They're far, far better at science communication than, say, the CDC (low bar, I know). We don't know who they are or who funds them, though there are certainly correlations with other, generally right-wing or libertarian, flavored groups. Given the number of times it's posted unironically here, it looks like a large number of people have been taken in by it.
- RickHull 5y ago> A lot of it is just straight-up fraud. Gideon Meyerowitz-Katz has documented this in some detail. Alexandros Marinos provides a counterpoint [1] > Reading the article, I was surprised (but not really) by the central role Gideon Meyerowitz-Katz (henceforth GidMK as is his much shorter Twitter handle) had played in the analysis. The man has a way to apparate wherever a person of influence takes a position on ivermectin. This is at least the third time I’ve observed the same sequence of events. > ... > I wanted to avoid focusing on GidMK himself, but the way the analysis comes out, this won’t be possible. I’ll try to keep things as dispassionate as possible without being fake, but I beseech the reader to understand that this isn’t your standard “Ad Hominem” argument. If Scott’s analysis depends on his trust on GidMK, it is paramount that I demonstrate that GidMK’s track record is not one deserving of that trust. > ... > I have to also note that GidMK is highly conscious of his feed, and is probably applying some automated means of blocking anyone supporting opposing views to his. Not only has he blocked me on Twitter, he seems to have blocked a double-digit percentage of my followers, many of which were not aware of the block until I asked them to check. My best hypothesis is that anyone “liking” anything I posted opposing his positions would automatically get blocked. There is more I could excerpt, but probably better to read the whole thing. 1. https://doyourownresearch.substack.com/p/a-conflict-of-blurred-visions https://doyourownresearch.substack.com/p/a-conflict-of-blurr...
- _djo_ 5y agoThis is not a counter-point, this is an ad hominem attack (despite its protestation to the contrary) that doesn’t address any of the serious problems that Meyerowitz-Katz found with those studies. Problems severe enough to force retractions from the relevant journals. The credibility of Meyerowitz-Katz (and others like him) rests on the quality of his claims and analyses, not on whether he blocks people on Twitter.